相关实验视频

Updated: Apr 24, 2026

The Goeckerman Regimen for the Treatment of Moderate to Severe Psoriasis

The Goeckerman Regimen for the Treatment of Moderate to Severe Psoriasis

Published on: July 11, 2013

基基-β-环氧德克斯含复合物改善了eugenol对牛皮病小鼠的皮肤间治疗效果

Yanyan Guo¹, Yingxue Yue¹, Huanhuan Wang¹

¹Affiliated Hospital of Integrated Traditional Chinese and Western Medicine, Nanjing University of Chinese Medicine, 100 Shizi Road, Nanjing, Jiangsu, 210028, China; Key Laboratory of New Drug Delivery System of Chinese Materia Medica, Jiangsu Province Academy of Chinese Medicine, Nanjing, Jiangsu, 210028, China.

European journal of pharmacology

|July 6, 2025

概括

这项研究开发了一种eugenol (EG) 和hydroxypropyl-β-cyclodextrin (HP-β-CD) 纳入复合物,以改善EG.

科学领域:

制药科学制药科学
皮肤病学皮肤病学
材料科学材料科学材料科学

背景情况:

尤根醇 (EG) 具有治疗潜力,但具有不良的溶解性和挥发性,限制了其临床使用.
环极素 (CD) 封装是一种提高难溶性药物的性能的策略.
xypropyl-β-cyclodextrin (HP-β-CD) 是环氧的衍生物,具有改善药物复合的特性.

研究的目的:

准备和表征一种含有原醇 (EG) 与xypropyl-β-cyclodextrin (HP-β-CD) 的纳入复合物.
为了评估EG-HP-β-CD纳入复合物的可溶性,稳定性和皮肤透过性质.
在小鼠牛皮病模型中评估EG-HP-β-CD纳入复合凝的疗效.

主要方法:

优化EG-HP-β-CD纳入复合物的准备过程.
使用各种分析技术对包含复合物的表征.
在体外释放研究,通过皮肤透的测试,以及在小鼠牛皮病模型中的体内疗效测试.

主要成果:

成功制备了EG-HP-β-CD纳入复合物,提高了溶解度和稳定性.
纳入复杂凝表现出持续释放的特性,符合Higuchi方程,在24小时内累积释放80%
该复合物显著降低了EG的透皮透,同时增加了皮肤保留,通过调节炎症标志物和JAK1/STAT3通路,在牛皮病模型中提高了疗效.

结论:

EG-HP-β-CD包容复合物有效地克服了欧原醇的局限性,增强了其可溶性,稳定性和通过皮肤传递.
开发的包括复合凝显示出有希望的持续释放和增加皮肤保留,从而产生卓越的抗皮疗效.
这项研究提供了一个有价值的策略,用于制定易挥发性油,用于通过皮肤治疗牛皮的治疗.

关键词:

循环德克斯林包含复杂的复合物尤金诺醇是一种在体外释放的体外释放.牛皮病是什么意思牛皮病通过皮肤进行的研究.

更多相关视频

A Facile and Efficient Approach for the Production of Reversible Disulfide Cross-linked Micelles

A Facile and Efficient Approach for the Production of Reversible Disulfide Cross-linked Micelles

Published on: December 23, 2016

Author Spotlight: Exploring Photodynamic Therapy with Curcumin in a Murine Model for Oral Candidiasis

Author Spotlight: Exploring Photodynamic Therapy with Curcumin in a Murine Model for Oral Candidiasis

Published on: October 27, 2023

相关概念视频

Bioavailability Enhancement: Drug Permeability Enhancement

Bioavailability Enhancement: Drug Permeability Enhancement

After oral administration, poor permeability often limits the rate at which drugs are absorbed through the intestinal epithelium. Enhancing drug permeability is crucial for effective therapy, and several strategies have been developed to overcome this challenge.One effective strategy involves the use of lipid-based formulations. These formulations enhance dissolution and solubility, targeting physiological mechanisms to increase drug absorption. This includes stimulating bile salt secretion,...

Bioavailability Enhancement: Drug Stability Enhancement and GI Retention

Bioavailability Enhancement: Drug Stability Enhancement and GI Retention

Improving a drug's stability in the gastrointestinal (GI) tract is paramount for enhancing its bioavailability and therapeutic effectiveness. Various strategies are employed to protect the drug from the harsh gastric milieu and to ensure its release and absorption at the desired site within the GI tract.Polymer coatings are one such method used to shield drugs from the stomach's acidic environment. By preventing premature drug release, these coatings improve the bioavailability of unstable...